Tex. Health & Safety Code § 491.057 · Subchapter B. DRUG DEVELOPMENT OF IBOGAINE TREATMENT
DRUG DEVELOPMENT CLINICAL TRIAL SITES.
Verbatim from the official edition
Text — Current through the 89th 2nd Called Legislative Session, 2025
For purposes of conducting a drug development clinical trial under this subchapter, only an institution of higher education or a hospital may serve as a trial site.
Notes and commentary — not statutory text
History
Added by Acts 2025, 89th Leg., R.S., Ch. 333 (S.B. 2308), Sec. 1, eff. June 11, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.htm
- Text hash
- sha256 dac1ba58c6b22284468cf95f03d1f9f2f845c952d9cb57b865ea096d61cf540e
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.